CAPMATINIB

1376 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking CAPMATINIB:

# Side effect Count
0 DEATH 229
1 PERIPHERAL SWELLING 178
2 FATIGUE 163
3 NAUSEA 155
4 OEDEMA PERIPHERAL 147
5 MALIGNANT NEOPLASM PROGRESSION 88
6 OEDEMA 76
7 DYSPNOEA 71
8 JOINT SWELLING 63
9 NON-SMALL CELL LUNG CANCER 61
See all common reactions for CAPMATINIB

CAPMATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METASTASES TO PERIPHERAL NERVOUS SYSTEM 1 0.1667
1 PLEURAL FLUID ANALYSIS ABNORMAL 1 0.1429
2 METASTASES TO LARYNX 1 0.0667
3 CLEAR CELL SARCOMA OF SOFT TISSUE 1 0.0500
4 NON-SMALL CELL LUNG CANCER STAGE IIIA 1 0.0400
5 NON-SMALL CELL LUNG CANCER STAGE III 1 0.0333
6 SARCOMATOID CARCINOMA 1 0.0303
7 CRANIOPLASTY 1 0.0303
8 BURSAL FLUID ACCUMULATION 1 0.0250
9 NON-SMALL CELL LUNG CANCER 61 0.0209
See all enriched reactions for CAPMATINIB